Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lipocine (LPCN)
NASDAQ:LPCN
Holding LPCN?
Track your performance easily
LPCN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.44 - $11.79
Previous Close$4.87
Volume65.56K
Average Volume (3M)27.43K
Market Cap
$26.04M
Enterprise Value$6.22M
Total Cash (Recent Filing)$19.82M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.71
Next Earnings
Mar 05, 2025EPS Estimate
-$0.37Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.76
Shares Outstanding5,347,940
10 Day Avg. Volume896,279
30 Day Avg. Volume27,431
Standard Deviation0.22
R-Squared0.09
Alpha-0.00225
Financial Highlights & Ratios
Price to Book (P/B)1.36
Price to Sales (P/S)3.29
Price to Cash Flow (P/CF)-2.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.36
Enterprise Value/Gross Profit-2.18
Enterprise Value/Ebitda-0.73
Forecast
1Y Price Target
$10.00Price Target Upside105.34% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Lipocine News
Ownership Overview
15.89% Insiders
5.18% Mutual Funds
<0.01% Other Institutional Investors
74.68% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
LPCN FAQ
What was Lipocine’s price range in the past 12 months?
Lipocine lowest stock price was $2.44 and its highest was $11.79 in the past 12 months.
What is Lipocine’s market cap?
Currently, no data Available
When is Lipocine’s upcoming earnings report date?
Lipocine’s upcoming earnings report date is Mar 05, 2025 which is in 73 days.
How were Lipocine’s earnings last quarter?
Lipocine released its earnings results on Nov 07, 2024. The company reported -$0.44 earnings per share for the quarter, beating the consensus estimate of -$0.485 by $0.045.
Is Lipocine overvalued?
According to Wall Street analysts Lipocine’s price is currently Undervalued.
Does Lipocine pay dividends?
Lipocine does not currently pay dividends.
What is Lipocine’s EPS estimate?
Lipocine’s EPS estimate is -$0.37.
How many shares outstanding does Lipocine have?
Lipocine has 5,347,940 shares outstanding.
What happened to Lipocine’s price movement after its last earnings report?
Lipocine reported an EPS of -$0.44 in its last earnings report, beating expectations of -$0.485. Following the earnings report the stock price went down -7.756%.
Which hedge fund is a major shareholder of Lipocine?
Currently, no hedge funds are holding shares in LPCN
---
Lipocine Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (105.34% Upside)
$10.00 (105.34% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.8%
Last 30 Days ▼ 3.7%
Last 30 Days ▼ 3.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
63.42%
12-Months-Change
Fundamentals
Return on Equity
-19.50%
Trailing 12-Months
Asset Growth
-16.38%
Trailing 12-Months
Company Description
Lipocine
Lipocine, Inc. operates as a pharmaceutical company, which engages in the research and development of treatment for use in men's and women's health through proprietary drug delivery technologies. It focuses on the oral testosterone replacement therapy and preterm birth prevention. The company was founded in 2011 and is headquartered in Salt Lake City, UT.
---
LPCN Stock 12 Month Forecast
Average Price Target
$10.00
▲(105.34% Upside)
Technical Analysis
Eton Pharmaceuticals
―
Ovid Therapeutics
―
Viking Therapeutics
―
Aclaris Therapeutics
―
Best Analysts Covering LPCN
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+2.80%
initiated a buy rating 3 months ago
Copying Scott Henry's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +2.80% per trade.
---